Scientists observe drug target that can reduce pain when activated
A research group at Hiroshima University observed a potential new target for chronic pain treatment. Further research using this receptor could lead to new, more effective drugs to use in pain-relieving treatment for chronic pain.
Conditions that cause chronic pain can be difficult to manage. These include sciatica, cancer and rheumatoid arthritis. Chronic pain mechanisms are complicated, which is one of the reasons why pain management is so difficult, explains Professor Norimitsu Morioka of the Department of Pharmacology, Graduate School of Biomedical & Health Sciences, Hiroshima University. This difficulty decreases the quality of life of patients that, in many cases, can suffer from constant pain with little to no relief. General-purpose pain-relieving medication is often ineffective. Even morphine, possibly the best painkiller according to Assistant Professor Yoki Nakamura, also of the Department of Pharmacology, can fail to inhibit pain in cancer patients.
“Chronic pain is increasing worldwide […] associated with increasing population,” warns Morioka. The increasing number of sufferers of chronic pain means the establishment of new therapeutics is urgent, hence why the results of these types of studies can have important consequences on healthcare for these patients.
Previous research had shown that activating a type of cell receptor (REV-ERBs) that sends chemical signals inside the cell to block the production of certain genes regulates pain-causing and inflammatory molecules inside the body. Such research had shown that a molecule used to ‘turn on’ the REV-ERBs had decreased the production of inflammatory molecules in immune cells but
“Nobody checked the effect of REV-ERBs agonist [stimulator] on nociceptive behaviors [pain reactions] or chronic pain so first we checked the effect of REV-ERBs agonist on chronic pain,” explains Nakamura.
Until now, research has also only looked into one type of pain model at a time. Morioka elaborates that
“I think it is not enough to reduce by one target […] I think it is important to cover a lot of molecules mediating chronic pain,” and REV-ERBs seems to be a fitting target “So it is very exciting.”
The research group applied this knowledge to determine if activating the nuclear receptor REV-ERBs in specialized spinal cord cells (astrocytes) results in pain relief in mice. The team treated mice with differing levels of pain sensitivity with molecules that turned on REV-ERBs. The molecules studied can be easily found in today’s pain-relieving drugs according to the team. To test whether there was a notable effect on pain; mice were touched with a filament on their hind paw. Pain was recorded when mice raised their paw away from the filament. Light touches made mice with chronic pain react whereas ‘normal’ mice only moved when the force was increased. Mice with chronic pain when treated with a REV-ERBs stimulator did not react to the lighter touches (depending on the type of chronic pain they had). Through these observations, the research group concluded they did not feel as much pain as the untreated mice with the same type of chronic pain.
Based on these results, the researchers believe that this new target for pain relief could benefit many types of chronic pain sufferers. They plan to perform further research and drug screening experiments to develop new drugs for various types of chronic pain relief.
Learn more: New target for chronic pain relief confirmed by scientists
The Latest on: Chronic pain relief
[google_news title=”” keyword=”chronic pain relief” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Chronic pain relief
- SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Painon May 13, 2024 at 12:27 pm
Randomized Placebo-Controlled Trial of 60-Day Percutaneous Peripheral Nerve Stimulation Treatment Indicates Relief of Persistent Postoperative Pain, and Improved Function After Knee Replacement Key ...
- Cannabis Gum: Would You Try Chewing Your Way To Pain Relief?on May 13, 2024 at 6:19 am
Well, how about chewing it just like nicotine gum? Cannabis is now being produced as a chewable gum for pain relief [1]. Millions of people all over the country, with the majority of them being ...
- What A Doctor Wants You To Know About Pelvic Floor Treatmenton May 13, 2024 at 5:14 am
In 'It's Not Hysteria,' Dr. Karen Tang outlines how pelvic floor problems are common, and pelvic physical therapy helps prevent pain and distressing vaginal and urinary symptoms.
- How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic painon May 12, 2024 at 10:40 pm
I see cannabis and psilocybin as promising therapies that can contribute to bridging that need. Given that an estimated 50 million Americans have chronic pain – meaning pain that persists for three ...
- Earthworms Inspire Medtronic’s Latest Chronic Pain Deviceon May 12, 2024 at 5:00 pm
They just happened to have the technology already built in. Inceptiv is a rechargeable, fully-implanted device aimed at delivering real-time treatment to patients experiencing chronic pain. The U.S.
- Chronic pain is a big problem. How cannabis and psilocybin could helpon May 12, 2024 at 5:00 pm
Given that an estimated 50 million Americans have chronic pain – meaning pain that persists for three months or more – I want to help understand how to effectively use cannabis and psilocybin as ...
- Laser Zaps Away Chronic Pain For Wounded Israeli Soldierson May 12, 2024 at 8:00 am
The laser system that Shane uses is a small hand-held device called “Handy Cure,” which is also available for use in the home. Shane, however, couples the laser treatment with acupuncture and other ...
- Global Chronic Pain Management Market: Set to Reach US$168.68 Billion by 2031on May 9, 2024 at 4:09 pm
The Global Chronic Pain Management Market was valued at US$ 93.31 billion in 2022 and is expected to attain a market size of US$ 168.68 billion by 2031 at a CAGR of 6.8% During the Forecast Period ...
- 4 Things You Should Know If You Take NSAIDs for Chronic Back Painon May 7, 2024 at 7:40 am
While it’s definitely okay—and common!—to take NSAIDs for long-term back issues, it’s best to do so armed with knowledge and, in some cases, under the guidance of a doctor. Here’s all the stuff you ...
- Treating chronic pain requires much more than medicationson May 6, 2024 at 4:59 pm
This type of treatment program typically takes place in an outpatient setting and lasts three to six weeks, eight hours a day, for five days a week. While in the program, kids with chronic pain ...
via Bing News